*Corresponding author:
Kwiatkowski Fabrice, Statistician (MSc), Statistics Unit, Centre Jean Perrin, FranceReceived: December 05, 2018; Published: December 14, 2018
DOI: 10.26717/BJSTR.2018.12.002211
To view the Full Article Peer-reviewed Article PDF
Context: Suicide risk evaluation has always been of importance for patients’ care, but it has recently become a major concern for clinical research. According to DSM-5 experts, new tools still need to be developed to better evaluate this risk. RSD scale (Risk for Suicide of Ducher) described hereafter, was created thirty years ago.
Methods: It consists in a hetero-questionnaire yielding a score from 0 to 10, 10 being the decisional level for the patient regarding a possible acting out. The scoring of the scale during the consultation by a psychiatrist or a physician does not need more than a few minutes. All studies that used RSD scale are included in this review.
Results: Outcomes and conclusions are synthetized to document its global metrologic properties. The scale has been tested in various situations (adolescents, adults, males and females, without/after a suicidal attempt) and in particular in a prospective trial to compare the efficacy of two antidepressants on depression and the suicidal risk in patients presenting with recurrent depressive disorder. In this latter, RSD was associated with 100% sensitivity and 87% specificity to predict suicide under treatment.
Conclusion: RSD seems to fit with recent guide-lines about suicide prevention but new studies in English-speaking countries are necessary to confirm its transcultural validity, and its interest in patients’ management as well as clinical trials.
Keywords :Suicide; Suicidal crisis; Scale; Questionnaire; RSD; Prevention; Review
Introduction| Discussion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China